Cardiovascular Imaging

Adults who had two or more midlife vascular risk factors had a significantly increased risk of elevated amyloid deposition in the brain later in life compared with those with no midlife vascular risk factors, according to a prospective cohort study.

New research has found that CT angiographies and stress tests could help predict when a patient is likely to suffer a heart attack or another serious cardiovascular event.

A review of five prospective, randomized clinical trials found that a coronary artery calcium (CAC) scan could be the most effective way to screen for coronary artery disease in asymptomatic patients.

Soon, payers will reward cost-effective, high-quality procedures, while both healthcare providers and patients increasingly will demand efficient, diagnostically accurate nuclear cardiology procedures with low radiation exposure.

At Brigham and Women’s Hospital, like many hospitals and medical centers across the country, cardiac PET is emerging as the go-to imaging modality for a growing list of clinical scenarios.

Experts recently offered a blueprint to make the choice easier when it comes to using cardiac PET to assess coronary artery disease, myocardial perfusion, viability, and ventricular function.

A randomized trial found that patients with suspected coronary heart disease who underwent cardiovascular magnetic resonance (CMR)–guided care had a significantly lower probability of unnecessary angiography within 12 months compared with patients who received National Institute for Health and Care Excellence (NICE) guidelines–directed care. The difference was not statistically different between CMR-guided care and myocardial perfusion scintigraphy (MPS)–guided care.

Is your organization updating or saying goodbye to SPECT? Take our quick 6 question survey and let us know. Look for results in the September/October issue.

Researchers have used PET/CT imaging to link stress-related amygdala activation in the brain with arterial inflammation and an increased risk of eventual cardiovascular disease events, according to results of a study presented today at ACC.16 in Chicago.

A systematic comparative effectiveness review of noninvasive testing for coronary artery disease found there was no significant difference in MI or all-cause mortality between testing strategies across settings and pretest risk groups. The Agency for Healthcare Research and Quality (AHRQ) conducted the review and released the report on March 29.

Although nearly one-fifth of adults with acute stroke syndromes had rapid neurological improvement before entering the hospital, 47 percent of that group was not discharged to their homes, according to a post-hoc analysis of a randomized trial.

Inpatient echocardiography is on the rise and, with it, questions about potential overutilization. A new study suggests that, on the contrary, during critical cardiovascular hospitalizations, echo may not get tapped enough.